ON PHOTOPHERESIS EFFICIENCY IN ANETODERMIA

V. A Molochkov; O. V Karzanov; A. A Prokofyev; Yu. V Molochkova

doi:10.17816/dv36830

Russian Journal of Skin and Venereal Diseases ›› 2013, Vol. 16 ›› Issue (5) : 22 -24. DOI: 10.17816/dv36830

Articles

research-article

ON PHOTOPHERESIS EFFICIENCY IN ANETODERMIA

Author information +

History +

PDF

Abstract

Extracorporeal photochemotherapy — photopheresis — was used for the treatment of anetodermia. A pronounced clinical effect (4 sessions every other day) was attained in the treatment of Schwenninger-Buzzi’a anetodermia (developing in the presence of Lewandowsky-Lutz verruciform epidermodysplasia) and Jadassohn ’s anetodermia. Photopheresis induced a trend to normalization of some immunological parameters. This is the first in world literature report about pronounced clinical efficiency and pathogenetic nature of photopheresis in anetodermia.

Keywords

anetodermia / photopheresis / immune status

Cite this article

Download citation ▾

V. A Molochkov, O. V Karzanov, A. A Prokofyev, Yu. V Molochkova. ON PHOTOPHERESIS EFFICIENCY IN ANETODERMIA. Russian Journal of Skin and Venereal Diseases, 2013, 16(5): 22-24 DOI:10.17816/dv36830

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Thomas J.E., Mehregan D.R., Holland J., Mehregan D.A. Familial anetoderma. Int. J. Dermatol. 2003; 42(1): 75—7.

[2]	Kineston D.P., Xia Y., Turiansky G.W. Anetoderma: a case report and review of the literature. Cutis. 2008; 81(6): 501—6.

[3]	Sparsa A., Piette J.C., Wechsler B., Amoura Z., Franc S.C. Anetoderma and its prothrombotic abnormalities. J. Am. Acad. Dermatol. 2003; 49(6): 1008—12.

[4]	Braun R.P., Borradori L., Chavaz R., Masouye I., French L., Saurat J.H. Treatment of primary anetoderma with colchicines. J. Am. Acad. Dermatol. 1998; 38(6, Pt 1): 1002—3.

[5]	Молочков В.А., Кочеткова Л.А., Прокофьев А.А. Анетодермия. Сборник статей научно-практической конференции «Актуальные вопросы дерматовенерологии и дерматоонкологии», 27—28 мая 2010, Москва. 2010: 17—9.

[6]	Edelson R.L. Photopheresis: a clinical relevant immunobiologic response modifier. Ann. N. Y Acad. Sci. 1991; 636: 154—64.

[7]	Lee K.H., Garro J. Engineering aspects of extracorporeal photochemotherapy. Yale J. Biol. Med. 1989; 62(6): 621—8.

[8]	Vowels B.R., Cassin M., Boufal M.H., Walsh L.J., Rook A.H. Extracorporeal phothochemotherapy induces the production of tumor necrosis factor alpfa by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J. Invest. Dermatol. 1992; 98(5): 686—92.

[9]	Zic J., Arzubiaga C., Salhany K.E., Parker R.A., Wilson D., Stricklin G.P., et al. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma. J. Am. Acad. Dermatol. 1992; 27(5, Pt 1): 729—36.

[10]	Gerber M., Gmeinhart B., Volc-Platzer B., Kalhs P., Greinix H.T., Knobler R. Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ESP). Bone Mаrrow Transplant. 1997; 19(5): 517—9.

[11]	Greinix H.T., Volc-Platzer B., Rabitsch W., Gmeinhart B., Guevara-Pineda C., Kalhs P., еt al. Successful use of eхtracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood. 1998; 92(5): 3098—104.

[12]	Owsianowski M., Gollnick H., Siegert W. Schwerdtfeger R., Orfanos C.E. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transplant. 1994; 14(5): 845—8.

[13]	Knobler R., Barr M.L., Couriel D.R., Ferrara J.L., French L.E., Jaksch P., et al. Extracorporeal photopheresis: past, present, and future. J. Am. Acad. Dermatol. 2009; 61(4): 652—65.